机构:[1]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics &[2]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing 102206, P. R. China[3]National Clinical Research Center for Aging and Medicine, Huashan Hospital & MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China[4]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing 102206, P. R. China[5]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing 102206, P. R. China[6]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing 102206, P. R. China[7]National Clinical Research Center for Aging and Medicine, Huashan Hospital & MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China[8]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing 102206, P. R. China Second Clinical Medicine Collage, Guangzhou University of Chinese Medicine, Guangzhou 510006, P. R. China Guizhou University School of Medicine, Guiyang 550025, P.R. China
As a hepadnavirus, hepatitis B virus (HBV) can cause damage to extrahepatic organs. The kidney is one of the organs that is more susceptible to damage. Research studies on HBV-associated glomerulonephritis (HBV-GN) have been going on for decades. However, the underlying molecular mechanism remains obscure. Here, we applied a tandem mass tag (TMT) isobaric labeling-based method to quantitatively profile the kidney proteome of HBV transgenic mice to illustrate the pathological mechanisms of HBV-GN. Weighted correlation network analysis, a clustering method for gene expression, is used to cluster proteins. Totally, we identified 127 proteins that were highly associated with HBV expression out of a total of 5169 quantified proteins. Among them, the downregulated solute carrier (SLC) family proteins are involved in the process of HBV-GN. We also found that IL1B was upregulated in the kidney tissue of HBV transgenic mice. These findings suggest that HBV disrupts the small molecule transport network of the kidney, which contributes to the occurrence of HBV-GN. The transporter, particularly SLC family 7 member 7 (SLC7A7), is involved in this process, which might serve as an intervention target for HBV-GN. All MS data have been deposited to the ProteomeXchange Consortium via the iProX partner repository with the data set identifier PXD016450.
基金:
Chinese National Basic Research ProgramsNational Basic Research Program of China [2017YFA0505100, 2017YFC0906700, 2017YFA0505700]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31670834, 31700723, 31870824, 31901037, 91839302]; Innovation Foundation of Medicine [16CXZ027, BWS17J032, 19SWAQ17, AWS17J008]; Chinese National Key Project Specialized for Infectious Diseases [2018ZX10301208-001-003, 2018ZX10302302]; Guangzhou science and technology innovation & development project [201802020016]; Unilever 21st Century Toxicity ProgramUnilever [MA-2018-02170N]; grant for Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences [2019RU006]; Foundation of State Key Lab of Proteomics [SKLP-K201704]
第一作者机构:[1]State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics &
通讯作者:
推荐引用方式(GB/T 7714):
Zuo Tao,Chen Peiru,Jing Sha,et al.Quantitative Proteomics Reveals the Development of HBV-Associated Glomerulonephritis Triggered by the Downregulation of SLC7A7.[J].JOURNAL OF PROTEOME RESEARCH.2020,19(4):1556-1564.doi:10.1021/acs.jproteome.9b00799.
APA:
Zuo Tao,Chen Peiru,Jing Sha,Zhang Tao,Chang Lei...&Xu Ping.(2020).Quantitative Proteomics Reveals the Development of HBV-Associated Glomerulonephritis Triggered by the Downregulation of SLC7A7..JOURNAL OF PROTEOME RESEARCH,19,(4)
MLA:
Zuo Tao,et al."Quantitative Proteomics Reveals the Development of HBV-Associated Glomerulonephritis Triggered by the Downregulation of SLC7A7.".JOURNAL OF PROTEOME RESEARCH 19..4(2020):1556-1564